Generic imatinib — impact on frontline and salvage therapy for CML
Crossref DOI link: https://doi.org/10.1038/nrclinonc.2016.59
Published Online: 2016-04-21
Published Print: 2016-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Gorkin, Larry
Kantarjian, Hagop
Text and Data Mining valid from 2016-04-21
Article History
First Online: 21 April 2016